CMO

Partner Content

Partner Content

The bar is set high for Medical Affairs (MA) talent: traditional capabilities are no longer sufficient to address

Oncology

Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.